Anne V. Ohlmann
University of Erlangen-Nuremberg
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anne V. Ohlmann.
The Journal of Neuroscience | 2005
Andreas Ohlmann; Michael Scholz; Andreas Goldwich; Bharesh K. Chauhan; Kristiane Hudl; Anne V. Ohlmann; Eberhart Zrenner; Wolfgang Berger; Ales Cvekl; Mathias W. Seeliger; Ernst R. Tamm
Norrie disease is an X-linked retinal dysplasia that presents with congenital blindness, sensorineural deafness, and mental retardation. Norrin, the protein product of the Norrie disease gene (NDP), is a secreted protein of unknown biochemical function. Norrie disease (Ndpy/-) mutant mice that are deficient in norrin develop blindness, show a distinct failure in retinal angiogenesis, and completely lack the deep capillary layers of the retina. We show here that the transgenic expression of ectopic norrin under control of a lens-specific promoter restores the formation of a normal retinal vascular network in Ndpy/- mutant mice. The improvement in structure correlates with restoration of neuronal function in the retina. In addition, lenses of transgenic mice with ectopic expression of norrin show significantly more capillaries in the hyaloid vasculature that surrounds the lens during development. In vitro, lenses of transgenic mice in coculture with microvascular endothelial cells induce proliferation of the cells. Transgenic mice with ectopic expression of norrin show more bromodeoxyuridine-labeled retinal progenitor cells at embryonic day 14.5 and thicker retinas at postnatal life than wild-type littermates, indicating a putative direct neurotrophic effect of norrin. These data provide direct evidence that norrin induces growth of ocular capillaries and that pharmacologic modulation of norrin might be used for treatment of the vascular abnormalities associated with Norrie disease or other vascular disorders of the retina.
Investigative Ophthalmology & Visual Science | 2004
Anne V. Ohlmann; Edith Adamek; Andreas Ohlmann; Elke Lütjen-Drecoll
Current Eye Research | 2005
Anne V. Ohlmann; Andreas Ohlmann; Ulrich Welge-Lussen; Christian Albrecht May
Investigative Ophthalmology & Visual Science | 2004
Kirsten H. Eibl; Bernhard Banas; Daniel Kook; Anne V. Ohlmann; Siegfried G. Priglinger; Anselm Kampik; Ulrich Welge-Luessen
Experimental Eye Research | 2006
Christian Albrecht May; Anne V. Ohlmann; H. Hammes; U.H.M. Spandau
Molecular Vision | 2011
Rudolf Fuchshofer; Ulrike B. Kottler; Anne V. Ohlmann; Ursula Schlötzer-Schrehardt; Anselm Jünemann; Friedrich E. Kruse; Andreas Ohlmann
Investigative Ophthalmology & Visual Science | 2006
Friedrich E. Kruse; T. Dietrich; Matthias Zenkel; Anne V. Ohlmann; J. Joergensen; U. Schloetzer–Schrehardt
Investigative Ophthalmology & Visual Science | 2006
U.B. Kottler; U. Schlötzer–Schrehardt; Friedrich E. Kruse; Anselm Jünemann; Anne V. Ohlmann
Investigative Ophthalmology & Visual Science | 2005
Andreas Ohlmann; R. Fuchshofer; Anne V. Ohlmann; Norbert Pfeiffer
Investigative Ophthalmology & Visual Science | 2004
Ernst R. Tamm; Anne V. Ohlmann; Michael Scholz; Andreas Goldwich; C. Flügel–Koch; Bharesh K. Chauhan; Ales Cvekl